. 2015 May 18;2015:854706. doi: 10.1155/2015/854706

Table 3.

Distribution of CD4⁺ lymphocyte subpopulations in peripheral blood of pSS patients and controls.

Patients	¹I-controls	²II-pSS Abs⁻	³III-pSS Abs⁺	P ^*	P ^*	P ^*
Patients	¹I-controls	²II-pSS Abs⁻	³III-pSS Abs⁺	I-II	I-III	II-III
CD4⁺ lymphocyte populations
CD4⁺CD25⁺
%⁴	10.00 ± 10.94	9.72 ± 6.1	11.64 ± 9.38	NS	NS	NS
A. count^#	183.6 ± 222.3	132.7 ± 106.0	106.1 ± 75.89	NS	0.036	NS
CD4⁺CD25^high
%⁴	1.97 ± 1.342	2.45 ± 1.71	2.71 ± 1.83	NS	NS	NS
A. count^#	32.13 ± 25.88	31.81 ± 25.92	24.39 ± 13.50	NS	NS	NS
CD4⁺FoxP3
%⁴	4.56 ± 4.73	5.19 ± 6.69	5.012 ± 4.68	NS	NS	NS
A. count^#	75.25 ± 82.62	59.45 ± 72.83	62.62 ± 105.0	NS	NS	NS
CD4⁺CD25⁺FoxP3
%⁴	1.12 ± 2.09	1.10 ± 0.90	0.90 ± 0.63	NS	NS	NS
A. count^#	19.12 ± 42.33	13.19 ± 10.79	10.21 ± 13.65	NS	NS	NS
CD4⁺CD25^highFoxP3
%⁴	0.27 ± 0.34	0.36 ± 0.31	0.35 ± 0.27	NS	NS	NS
A. count^#	4.45 ± 6.9	4.039 ± 2.91	3.26 ± 2.81	NS	NS	NS
CD4⁺CD25^lowFoxP3
%⁴	0.84 ± 1.75	0.78 ± 0.73	0.57 ± 0.51	NS	NS	NS
A. count^#	14.57 ± 35.46	9.64 ± 9.612	6.71 ± 12.78	NS	0.017	NS
Th17
%⁴	2.08 ± 1.31	0.85 ± 1.08	1.51 ± 2.89	0.0003	0.004	NS
A. count^#	34.44 ± 21.02	9.12 ± 10.89	10.89 ± 22.71	<0.0001	<0.0001	NS

¹I group: healthy controls; ²II group: pSS patients without anti-SSA/SSB; ³III group: pSS patients with anti-SSA and/or anti-SSB; %⁴: proportion of all CD4⁺ lymphocytes; A. count^#: absolute count of cells in 1 μL of blood. ^*Mann-Whitney test. NS: not significant.